Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Week In Review: Samsung Biologics Signs $1 Billion Manufacturing Contract With US Biopharma By: TalkMarkets July 06, 2024 at 14:20 PM EDT Samsung Biologics, a Korean CDMO, signed a $1.06 billion agreement to provide manufacturing services for an unnamed US pharma. The agreement is the largest that Samsung Bio has made since it was founded in 2011. Read More >> Related Stocks: Amgen ESAIY Innovent Biologics Inc Takeda Pharmaceutical Ltd ADR Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Week In Review: Samsung Biologics Signs $1 Billion Manufacturing Contract With US Biopharma By: TalkMarkets July 06, 2024 at 14:20 PM EDT Samsung Biologics, a Korean CDMO, signed a $1.06 billion agreement to provide manufacturing services for an unnamed US pharma. The agreement is the largest that Samsung Bio has made since it was founded in 2011. Read More >> Related Stocks: Amgen ESAIY Innovent Biologics Inc Takeda Pharmaceutical Ltd ADR